Why the study?
Early diagnosis and treatment determine prognosis in pediatric endocardial fibroelastosis, but the potential unintended consequences of sedation and biopsy during acute heart failure require comprehensive consideration.
Highlights the need for caution and comprehensive consideration before using sedation and endomyocardial biopsy in pediatric patients with acute heart failure due to endocardial fibroelastosis.
Answers are grounded in this paper and cite their sources.
Raises awareness of EFE as rare pediatric AHF mimic; leaves open need for prospective studies before changing practice.
Endocardial fibroelastosis (EFE) is commonly considered to be an inflammatory reactive lesion of hyperplasia and deposition of tissue fibers and collagen in the endocardium and/or subendocardium, which is strongly associated with endocardial sclerosis, ventricular remodeling and acute and chronic heart failure, and is one of the important causes for pediatric heart transplantation. Early diagnosis and treatment are the key factors in determining the prognosis of the children. In this paper, we would like to highlight the potential unintended consequences of the use of sedation and biopsy for pediatric acute heart failure caused by EFE and the comprehensive considerations prior to clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Xin et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: